## **Core Concept**
Anticentromere antibodies (ACA) are a type of autoantibody that targets the centromere region of chromosomes. These antibodies are commonly found in patients with limited systemic scleroderma, also known as limited systemic sclerosis (lSSc). The presence of ACA is a diagnostic marker and is associated with a distinct clinical subset of scleroderma.

## **Why the Correct Answer is Right**
The correct answer, **limited systemic scleroderma (lSSc)**, is associated with anticentromere antibodies because these patients typically have a more benign disease course compared to those with diffuse systemic scleroderma. ACA-positive patients often present with **CREST syndrome**, which stands for:
- **C**alcinosis
- **R**aynaud's phenomenon
- **E**sophageal dysmotility
- **S**clerodactyly
- **T**elangiectasia

## **Why Each Wrong Option is Incorrect**
- **Option A:** **Rheumatoid Arthritis (RA)** is not typically associated with anticentromere antibodies. RA is more commonly associated with rheumatoid factor (RF) and anti-citrullinated protein antibodies (ACPAs).
- **Option B:** **Systemic Lupus Erythematosus (SLE)** can have various autoantibodies, but anticentromere antibodies are not characteristically associated with SLE. SLE is more commonly linked with antibodies against nuclear components like anti-dsDNA and anti-Sm.
- **Option D:** **Diffuse Systemic Scleroderma** is actually less commonly associated with anticentromere antibodies. Instead, it is more frequently linked with anti-Scl-70 (topoisomerase I) antibodies, which are associated with a more severe disease course.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that the presence of **anticentromere antibodies** is highly suggestive of **limited systemic scleroderma (lSSc)**, and these patients often have a relatively good prognosis compared to those with diffuse systemic scleroderma. The CREST syndrome is a classic association that helps in clinical diagnosis.

## **Correct Answer:** B. Limited systemic scleroderma.